Hologic to Present at the 29th Annual Canaccord Adams Global Growth Conference
PRNewswire-FirstCall
BEDFORD, Mass.

BEDFORD, Mass., July 13, 2009  /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Chief Financial Officer, will present at the 29th Annual Canaccord Adams Global Growth Conference in Boston, MA on Thursday, August 13, 2009 at 8:30 a.m. (Eastern).

Interested parties are invited to listen to live audio webcasts of Hologic's investor presentations on the investor section of the company's website at www.hologic.com/investor. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

Contact:

Deborah Gordon

Vice President, Investor Relations

Hologic, Inc.

(781) 999-7716